MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices

is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X® and DX™ wound imaging devices. These are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications.

About DocNow:

DocNow is an EHR and virtual care platform purpose-built for post-acute providers. With solutions that simplify documentation, improve outcomes, and streamline clinical and administrative operations, DocNow supports care teams across Skilled Nursing Facilities, Long-Term Care, and Home Health environments.

Photo - https://mma.prnewswire.com/media/2675326/MolecuLight_MolecuLight_and_DocNow_Announce_Integration_for_Seam.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/moleculight-and-docnow-announce-integration-for-seamless-data-and-image-transfer-for-dx-devices-302440418.html

@ prnewswire.co.uk

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.